Roman Nawroth

5PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2026
Integration of a multimeric STAT consensus site into the adenoviral genome to interfere with IFN signaling represents a novel concept to improve oncolytic virotherapy.

|Oct 27, 2024
CDK4/6 inhibition initiates cell cycle arrest by nuclear translocation of RB and induces a multistep molecular response.

Ting Hong, Anna C Hogger, Dongbiao Wang

|Mar 09, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.

Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck

|Aug 10, 2022
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.

Jana Koch, Sebastian J Schober, Sruthi V Hindupur

|Jan 23, 2018
Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.

Anuja Sathe, Géraldine Chalaud, Immanuel Oppolzer

Pageof 1

Frequent Collaborators

2 joint publications

Sebastian Johannes Schober

2 joint publications

Per Sonne Holm

2 joint publications

Klaus Mantwill

1 joint publications

Jana Koch